RHHBY

58.4600.92%
RP

Richard P. Lifton

Non-Executive Independent Director

Dr. Prof. Richard P. Lifton, Ph.D. MD, serves as Member of the Board at Roche Venture Fund. He held this position on 2015. He serves as Professor of Medicine and Molecular Biophysics and Biochemistry from Yale University School of Medicine. Dr. Lifton serves as a Member of the Scientific Advisory Board of Ernest Gallo Clinic and Research Center. He serves as a Member of the Scientific Resource Board at Genentech, Inc. He serves as a Member of Medical Advisory Board at Howard Hughes Medical Institute. He serves as a Director of Tusk Therapeutics Ltd. He has been Director of Genentech, Inc. He has been a Non-Executive Independent Director of Roche Holding AG since 2015. He has been Investigator, Howard Hughes Medical Institute, Maryland, USA since 1994; has been Adjunct Professor of Genetics and Internal Medicine, Yale University School of Medicine, Connecticut, USA since 2016 and President of The Rockefeller University, New York City, New York, USA since 2016. He served as Chief Medical Resident, Brigham & Women's Hospital, Massachusetts, USA from 1986 to 1987; Instructor in Medicine, Brigham & Women's Hospital, Massachusetts, USA from 1986 to 1990; Assistant Professor Medicine, Harvard Medical School, Massachusetts, USA from 1991 to 1993; Assistant Professor, Medicine & Genetics, Yale University School of Medicine, Connecticut, USA from 1993 to 1994; Associate Professor, Medicine & Genetics, Yale University School of Medicine, Connecticut, USA from 1994 to 1997; Professor, Internal Medicine & Genetics, Yale University School of Medicine, Connecticut, USA from 1997 to 2016; Director, Yale Center for Human Genetics & Genomics, Yale University School of Medicine, Connecticut, USA from 1998 to 2016; Chairman, Department of Genetics, Yale University School of Medicine, Connecticut, USA from 1998 to 2016 Sterling Professor of Genetics, Yale University School of Medicine, Connecticut, USA from 2002 to 2016 and Executive Director, Yale Center for Genome Analysis, Yale University School of Medicine, Connecticut, USA from 2009 to 2016. His Other Activities / Memberships includes: Chair, Scientific Supervisory Board, Curagen Corporation, USA from 1996 to 2002; Scientific Advisory Board, Merck & Co., USA from 2000 to 2002 Chair, Scientific Advisory Board, Merck & Co., USA from 2002 to 2004; Advisor to President, Merck Research Laboratories, Merck & Co., USA from 2004 to 2014; Member of the Governing Council, The National Academy of Sciences, USA from 2012 to 2015. He has been Member, Scientific Advisory Board, The Simons Foundation Autism Research, and USA since 2014 and served as this position from 2007 to 2010. He has been with Breakthrough Prize in Life Sciences Jury, New York, USA since 2014; The Rockefeller University, Board of Trustees, New York City, New York, USA since 2016; Rockefeller Archive Center, Director, New York City, New York, USA since 2016 and New York Genome Center, Board of Directors, New York City, New York, USA since 2016. He is Awards / Honors includes: 1998 Homer Smith Award, American Society of Nephrology; 1999 Novartis Award for Hypertension Research; 2000 Pasarow Foundation, Medical Research Award; 2001 Elected to National Academy of Sciences; 2002 The Basic Research Prize, American Heart Association; 2002 Elected to Institute of Medicine; 2002 Richard Bright Award; 2003 Roy O. Greep Award, The Endocrine Society; 2006 Robert Tigerstedt Award, International Society of Hypertension; 2007 Alfred Newton Richards Award, International Society of Nephrology; 2008 Wiley Prize in Biomedical Sciences; 2012 Elected to American Academy of Arts and Sciences; 2014 Breakthrough Prize in Life Sciences and 2015 Arthur Kornberg and Paul Berg Lifetime Achievement Award in Biomedical Sciences, Stanford. He holds BA in Biology at Dartmouth College, USA 1975, MD at Stanford University, USA in 1982 and also PhD, Biochemistry, Stanford University, USA in 1986.

Positions